EPIVIR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 49702-203
  • Package NDC 49702-203-18
  • Application number NDA020564
  • SPL ID 38eff3e4-ae02-40be-9f8a-5e2d99113447
  • SPL set ID 89226149-47fa-4f7d-bb1f-1aa7034486b8
  • UNII 2T8Q726O95
  • RxCUI 152931
  • RxCUI 152932
  • RxCUI 199147
  • RxCUI 199148
  • RxCUI 349491
  • RxCUI 352230

What the source publishes

Labeler
ViiV Healthcare Company
Active ingredients
lamivudine
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:49702-203_38eff3e4-ae02-40be-9f8a-5e2d99113447
{
  "name": "EPIVIR",
  "splId": "38eff3e4-ae02-40be-9f8a-5e2d99113447",
  "labels": [
    {
      "setId": "89226149-47fa-4f7d-bb1f-1aa7034486b8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89226149-47fa-4f7d-bb1f-1aa7034486b8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=89226149-47fa-4f7d-bb1f-1aa7034486b8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "ViiV Healthcare Company",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, FILM COATED in 1 BOTTLE (49702-203-18)",
      "package_ndc": "49702-203-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20101004"
    }
  ],
  "productId": "49702-203_38eff3e4-ae02-40be-9f8a-5e2d99113447",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "49702-203",
  "deaSchedule": null,
  "genericName": "lamivudine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LAMIVUDINE",
      "strength": "150 mg/1"
    }
  ],
  "applicationNumber": "NDA020564",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20101004",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175656",
      "N0000175462",
      "N0000009947"
    ],
    "upc": [
      "0349702204133",
      "0349702203181"
    ],
    "unii": [
      "2T8Q726O95"
    ],
    "rxcui": [
      "152931",
      "152932",
      "199147",
      "199148",
      "349491",
      "352230"
    ],
    "spl_set_id": [
      "89226149-47fa-4f7d-bb1f-1aa7034486b8"
    ],
    "pharm_class_epc": [
      "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
      "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "ViiV Healthcare Company"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:49702-203_38eff3e4-ae02-40be-9f8a-5e2d99113447"